Literature DB >> 16771944

Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life.

Ann Danoff1, Oona Khan, David W Wan, Lainie Hurst, Daniel Cohen, Craig T Tenner, Edmund J Bini.   

Abstract

OBJECTIVES: Although sexual dysfunction has been reported in patients with hepatitis C virus (HCV) infection, little is known about this association. The aims of this study were to determine the prevalence of sexual dysfunction among men with chronic HCV infection and to evaluate the impact of sexual dysfunction on health-related quality of life (HRQOL).
METHODS: We prospectively enrolled 112 HCV positive men and 239 HCV negative controls, and all patients completed validated questionnaires to assess sexual function (Brief Male Sexual Function Inventory [BMSFI]), depression (Beck Depression Inventory), and HRQOL (Medical Outcomes Study Short Form-36). The BMSFI assessed sexual drive, erection, ejaculation, sexual problem assessment, and overall sexual satisfaction.
RESULTS: HCV positive men had significantly more sexual dysfunction than control subjects across all five domains of the BMFSI. In addition, HCV-infected men were significantly more likely than controls to not be sexually satisfied (53.6% vs 28.9%, p<0.001) and this remained statistically significant after adjusting for age, race, and other potential confounding variables (OR=3.36; 95% CI, 1.59-7.13). In the 241 individuals without depression, HCV positive men were significantly more likely to not be sexually satisfied as compared with control subjects (47.5% vs 11.0%, p<0.001). HCV-infected men who were not sexually satisfied scored significantly worse in six of eight domains of HRQOL as compared with HCV-infected men who were sexually satisfied.
CONCLUSIONS: Sexual dysfunction is highly prevalent in men with chronic HCV infection, is independent of depression, and is associated with a marked reduction in HRQOL.

Entities:  

Mesh:

Year:  2006        PMID: 16771944     DOI: 10.1111/j.1572-0241.2006.00544.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  14 in total

1.  Sexual quality of life is impaired in patients with chronic hepatitis C.

Authors:  J Vergniol; S Duc; G Hou; J B Hiriart; J Foucher; F Chenus; C Fabères; F Chermak; A Lafournière; N Souakri; V de Lédinghen
Journal:  Int J Impot Res       Date:  2016-02-11       Impact factor: 2.896

Review 2.  Male sexual disturbances in liver diseases: what do we know?

Authors:  M Durazzo; A Premoli; C Di Bisceglie; S Bo; E Ghigo; C Manieri
Journal:  J Endocrinol Invest       Date:  2010 Jul-Aug       Impact factor: 4.256

3.  Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.

Authors:  Herbert L Bonkovsky; Kristin K Snow; Peter F Malet; Carla Back-Madruga; Robert J Fontana; Richard K Sterling; Clark C Kulig; Adrian M Di Bisceglie; Timothy R Morgan; Jules L Dienstag; Marc G Ghany; David R Gretch
Journal:  J Hepatol       Date:  2006-11-27       Impact factor: 25.083

4.  Does Treatment of Erectile Dysfunction With PDE 5 Inhibitor Tadalafil Improve Quality of Life in Male Patients With Compensated Chronic Liver Disease? A Prospective Pilot Study.

Authors:  Alok Kumar; Vivek Saraswat; Gaurav Pande; Rajesh Kumar
Journal:  J Clin Exp Hepatol       Date:  2022-01-23

5.  Erectile Dysfunction in Cirrhosis: Its Prevalence and Risk Factors.

Authors:  Rakesh K Jagdish; Ahmed Kamaal; Saggere M Shasthry; Jaya Benjamin; Rakhi Maiwall; Ankur Jindal; Ashok Choudhary; Vijayaraghavan Rajan; Vinod Arora; Ankit Bhardwaj; Guresh Kumar; Manoj Kumar; Shiv K Sarin
Journal:  J Clin Exp Hepatol       Date:  2022-05-10

6.  Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.

Authors:  K K Snow; H L Bonkovsky; R J Fontana; H-Y Kim; R K Sterling; A M Di Bisceglie; T R Morgan; J L Dienstag; M G Ghany
Journal:  Aliment Pharmacol Ther       Date:  2010-01-12       Impact factor: 8.171

7.  Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With Liver Cirrhosis.

Authors:  Jitender Thakur; Sahaj Rathi; Sandeep Grover; Madhu Chopra; Swastik Agrawal; Sunil Taneja; Ajay Duseja; Anil Bhansali; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2018-08-18

8.  Sexual dysfunction in males with hepatitis C virus: relevance to histopathologic changes and peginterferon treatment.

Authors:  Kamal A El-Atrebi; Mohamed A El-Atrebi; Hala T El-Bassyouni
Journal:  Saudi J Gastroenterol       Date:  2011 Nov-Dec       Impact factor: 2.485

9.  Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial.

Authors:  Mostafa Yakoot; Amel Salem
Journal:  BMC Gastroenterol       Date:  2012-04-12       Impact factor: 3.067

10.  Influence of healthcare-associated factors on the efficacy of hepatitis C therapy.

Authors:  Mohamed A Daw; Aghynya A Dau; Mohamed M Agnan
Journal:  ScientificWorldJournal       Date:  2012-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.